NATURE . COM {}

Matching Content Categories {📚}

• Science
• Education
• Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$63,100 per month
Our estimates place Nature.com's monthly online earnings from display ads at $42,042 to $115,616.

Keywords {🔍}

cells, irx, gefitinib, cancer, nanog, cell, expression, pcgr, fig, article, resistance, properties, google, scholar, china, lung, western, cas, stemlike, ohd, treatment, stem, blotting, protein, nsclc, tumor, signaling, combination, tgfβ, cytotoxicity, results, group, analysis, nature, egfrtki, increased, inhibited, stemness, experiments, transfected, usa, sirna, growth, celllike, treated, significantly, levels, assay, nanjing, viability,

Topics {✒️}

nature portfolio beta-catenin-mediated epithelial-mesenchymal transition vdr/plc-gamma1/tgf-beta1/pathway serum‐free opti‐mem media research groups privacy policy tgf-β/smad signaling-induced irx4 tgf-β1/smad3 signaling pathway tgf-β/smad signaling pathway28 nature small-molecule multi-kinase inhibitor20 advertising erk1/2-mzf1 signaling pathway reprints tgf-β1/smad3 signaling japan activating stat3/cxcl1 axis 2d3 signaling-induced decreases egfr-tyrosine kinase inhibitors small-cell lung cancer egfr-tki resistant cells irx4-mediated cancer stem potentiates cell death social media poor egfr-tki sensitivity inhibit egfr-tki resistance irx4-expressing cell lines nanog-mediated stem cell state key laboratory regulating egfr-tki resistance cd44+cd133+ pc-9/gr cells increase egfr-tki resistance high tgf-β1 levels irx-family genes participate egfr-mutant nsclc cells9 contract number hh20190622lhy-lv03 ventricular-specific progenitor cell multi-directional differentiation potential pnanog-luc reporter activity irx4+mouse embryonic cells original author tgf-β1 induced permissions sirna/plasmid‐lipid complexes lung cancer progression tyrosine kinase inhibitors 20 ng/ml tgf-β1 delayed development cell death dis pre-clinical models support

Questions {❓}

• How IRX4 controls gefitinib cytotoxicity?
• How to regulate IRX4-mediated cancer stem-like properties and gefitinib resistance?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells
         description:Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
         datePublished:2020-08-20T00:00:00Z
         dateModified:2020-08-20T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41419-020-02908-w
         keywords:
            Cancer
            Cancer therapy
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Immunology
            Cell Culture
            Antibodies
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig8_HTML.png
         isPartOf:
            name:Cell Death & Disease
            issn:
               2041-4889
            volumeNumber:11
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Zhirong Jia
               url:http://orcid.org/0000-0002-7381-5150
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yameng Zhang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aiwen Yan
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Meisa Wang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qiushuang Han
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kaiwei Wang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jie Wang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:the First Affiliated Hospital of Xinjiang Medical University
                     address:
                        name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chen Qiao
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:China Pharmaceutical University
                     address:
                        name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhenzhen Pan
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chuansheng Chen
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dong Hu
               affiliation:
                     name:Anhui University of Science and Technology
                     address:
                        name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Xuansheng Ding
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:China Pharmaceutical University
                     address:
                        name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells
      description:Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
      datePublished:2020-08-20T00:00:00Z
      dateModified:2020-08-20T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41419-020-02908-w
      keywords:
         Cancer
         Cancer therapy
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Immunology
         Cell Culture
         Antibodies
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig8_HTML.png
      isPartOf:
         name:Cell Death & Disease
         issn:
            2041-4889
         volumeNumber:11
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Zhirong Jia
            url:http://orcid.org/0000-0002-7381-5150
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yameng Zhang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aiwen Yan
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Meisa Wang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qiushuang Han
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kaiwei Wang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jie Wang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:the First Affiliated Hospital of Xinjiang Medical University
                  address:
                     name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chen Qiao
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:China Pharmaceutical University
                  address:
                     name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhenzhen Pan
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chuansheng Chen
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dong Hu
            affiliation:
                  name:Anhui University of Science and Technology
                  address:
                     name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Xuansheng Ding
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:China Pharmaceutical University
                  address:
                     name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Disease
      issn:
         2041-4889
      volumeNumber:11
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:the First Affiliated Hospital of Xinjiang Medical University
      address:
         name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:Anhui University of Science and Technology
      address:
         name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Zhirong Jia
      url:http://orcid.org/0000-0002-7381-5150
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Yameng Zhang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Aiwen Yan
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Meisa Wang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Qiushuang Han
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Kaiwei Wang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Jie Wang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
            name:the First Affiliated Hospital of Xinjiang Medical University
            address:
               name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
               type:PostalAddress
            type:Organization
      name:Chen Qiao
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
            name:China Pharmaceutical University
            address:
               name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Zhenzhen Pan
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Chuansheng Chen
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Dong Hu
      affiliation:
            name:Anhui University of Science and Technology
            address:
               name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Xuansheng Ding
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
            name:China Pharmaceutical University
            address:
               name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China

Social Networks {👍}(1)

• https://twitter.com/cddpress

External Links {🔗}(114)

• What are the earnings of https://orcid.org/0000-0002-7381-5150?
• How much revenue does https://doi.org/10.1016%2FS0140-6736%2817%2933326-3 produce monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Global%20surveillance%20of%20trends%20in%20cancer%20survival%202000-14%20%28CONCORD-3%29%3A%20analysis%20of%20individual%20records%20for%2037%20513%20025%20patients%20diagnosed%20with%20one%20of%2018%20cancers%20from%20322%20population-based%20registries%20in%2071%20countries&journal=Lancet&doi=10.1016%2FS0140-6736%2817%2933326-3&volume=391&pages=1023-1075&publication_year=2018&author=Allemani%2CC earn?
• Discover the revenue of https://doi.org/10.1200%2FJCO.2012.45.3753
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Genotyping%20and%20genomic%20profiling%20of%20non-small-cell%20lung%20cancer%3A%20implications%20for%20current%20and%20future%20therapies&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.2012.45.3753&volume=31&pages=1039-1049&publication_year=2013&author=Li%2CT&author=Kung%2CHJ&author=Mack%2CPC&author=Gandara%2CDR each month?
• Revenue of https://doi.org/10.6004%2Fjnccn.2018.0062
• Earnings of http://scholar.google.com/scholar_lookup?&title=NCCN%20guidelines%20insights%3A%20non-small%20cell%20lung%20cancer%2C%20Version%205.2018&journal=J.%20Natl%20Compr.%20Canc%20Netw.&doi=10.6004%2Fjnccn.2018.0062&volume=16&pages=807-821&publication_year=2018&author=Ettinger%2CDS
• Explore the financials of https://doi.org/10.1038%2Fcddis.2014.447
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=A%20novel%20antagonist%20to%20the%20inhibitors%20of%20apoptosis%20%28IAPs%29%20potentiates%20cell%20death%20in%20EGFR-overexpressing%20non-small-cell%20lung%20cancer%20cells&journal=Cell%20Death%20Dis.&doi=10.1038%2Fcddis.2014.447&volume=5&publication_year=2014&author=Lee%2CSH
• Learn about the earnings of https://doi.org/10.2174%2F1574887114666181205155211
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Advanced%20non-small%20cell%20lung%20cancer%20with%20activating%20epidermal%20growth%20factor%20receptor%20mutation%3A%20first%20line%20treatment%20and%20beyond&journal=Rev.%20Recent%20Clin.%20Trials&doi=10.2174%2F1574887114666181205155211&volume=14&pages=120-128&publication_year=2019&author=Rocco%2CD&author=Battiloro%2CC&author=Gravara%2CLD&author=Gridelli%2CC?
• How much revenue does https://link.springer.com/doi/10.1007/s40264-018-0772-x generate?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Safety%20and%20tolerability%20of%20epidermal%20growth%20factor%20receptor%20%28EGFR%29%20tyrosine%20kinase%20inhibitors%20in%20oncology&journal=Drug%20Saf.&doi=10.1007%2Fs40264-018-0772-x&volume=42&pages=181-198&publication_year=2019&author=Shah%2CRR&author=Shah%2CDR?
• https://doi.org/10.1016%2Fj.resinv.2018.09.001's financial summary
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Resistance%20to%20molecularly%20targeted%20therapy%20in%20non-small-cell%20lung%20cancer&journal=Respir.%20Investig.&doi=10.1016%2Fj.resinv.2018.09.001&volume=57&pages=20-26&publication_year=2019&author=Asao%2CT&author=Takahashi%2CF&author=Takahashi%2CK?
• How much does https://doi.org/10.1111%2Fcas.12749 rake in every month?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Acquisition%20of%20cancer%20stem%20cell-like%20properties%20in%20non-small%20cell%20lung%20cancer%20with%20acquired%20resistance%20to%20afatinib&journal=Cancer%20Sci.&doi=10.1111%2Fcas.12749&volume=106&pages=1377-1384&publication_year=2015&author=Hashida%2CS make?
• https://doi.org/10.1038%2Fs41467-018-05626-2's financial summary
• What's the income of http://scholar.google.com/scholar_lookup?&title=Notch3-dependent%20beta-catenin%20signaling%20mediates%20EGFR%20TKI%20drug%20persistence%20in%20EGFR%20mutant%20NSCLC&journal=Nat.%20Commun.&doi=10.1038%2Fs41467-018-05626-2&volume=9&publication_year=2018&author=Arasada%2CRR?
• How much profit does https://doi.org/10.1111%2Fcrj.12976 generate?
• How much profit does http://scholar.google.com/scholar_lookup?&title=CD146-mediated%20acquisition%20of%20stemness%20phenotype%20enhances%20tumour%20invasion%20and%20metastasis%20after%20EGFR-TKI%20resistance%20in%20lung%20cancer&journal=Clin.%20Respir.%20J.&doi=10.1111%2Fcrj.12976&volume=13&pages=23-33&publication_year=2019&author=Zhang%2CF make?
• How much does https://doi.org/10.1158%2F0008-5472.CAN-12-4136 generate monthly?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20to%20EGFR%20inhibitors%20is%20associated%20with%20a%20manifestation%20of%20stem%20cell-like%20properties%20in%20cancer%20cells&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-12-4136&volume=73&pages=3051-3061&publication_year=2013&author=Shien%2CK?
• https://doi.org/10.1016%2Fj.canlet.2018.07.020 income
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Genome-wide%20identification%20of%20transcription%20factors%20that%20are%20critical%20to%20non-small%20cell%20lung%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2018.07.020&volume=434&pages=132-143&publication_year=2018&author=Zhang%2CDL?
• Income figures for https://link.springer.com/doi/10.1007/s00429-016-1326-6
• http://scholar.google.com/scholar_lookup?&title=Expression%20patterns%20of%20Irx%20genes%20in%20the%20developing%20chick%20inner%20ear&journal=Brain%20Struct.%20Funct.&doi=10.1007%2Fs00429-016-1326-6&volume=222&pages=2071-2092&publication_year=2017&author=Cardena-Nunez%2CS's revenue stream
• How much cash flow does https://doi.org/10.1038%2Fncomms1301 have monthly?
• Profit of http://scholar.google.com/scholar_lookup?&title=An%20evolutionarily%20conserved%20three-dimensional%20structure%20in%20the%20vertebrate%20Irx%20clusters%20facilitates%20enhancer%20sharing%20and%20coregulation&journal=Nat.%20Commun.&doi=10.1038%2Fncomms1301&volume=2&publication_year=2011&author=Tena%2CJJ
• How much does https://doi.org/10.1002%2Fstem.2486 earn?
• How much does http://scholar.google.com/scholar_lookup?&title=Irx4%20marks%20a%20multipotent%2C%20ventricular-specific%20progenitor%20cell&journal=Stem%20Cells&doi=10.1002%2Fstem.2486&volume=34&pages=2875-2888&publication_year=2016&author=Nelson%2CDO net monthly?
• What's the income generated by https://doi.org/10.1016%2Fj.mcn.2008.11.003 each month?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Formation%20of%20posterior%20cranial%20placode%20derivatives%20requires%20the%20Iroquois%20transcription%20factor%20irx4a&journal=Mol.%20Cell%20Neurosci.&doi=10.1016%2Fj.mcn.2008.11.003&volume=40&pages=328-337&publication_year=2009&author=Feijoo%2CCG&author=Saldias%2CMP&author=Paz%2CJF&author=Gomez-Skarmeta%2CJL&author=Allende%2CML have monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22213310 net monthly?
• See how much http://scholar.google.com/scholar_lookup?&title=Vitamin%20D%3A%20potential%20in%20the%20prevention%20and%20treatment%20of%20lung%20cancer&journal=Anticancer%20Res.&volume=32&pages=211-221&publication_year=2012&author=Norton%2CR&author=O%E2%80%99Connell%2CMA makes per month
• What's the monthly money flow for https://doi.org/10.1016%2Fj.jsbmb.2012.09.022?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Differential%20response%20to%201alpha%2C25-dihydroxyvitamin%20D3%20%281alpha%2C25%28OH%292D3%29%20in%20non-small%20cell%20lung%20cancer%20cells%20with%20distinct%20oncogene%20mutations&journal=J.%20Steroid%20Biochem%20Mol.%20Biol.&doi=10.1016%2Fj.jsbmb.2012.09.022&volume=136&pages=264-270&publication_year=2013&author=Zhang%2CQ?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31002352 generate?
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=1alpha%2C25Dihydroxyvitamin%20D3%20restrains%20stem%20celllike%20properties%20of%20ovarian%20cancer%20cells%20by%20enhancing%20vitamin%20D%20receptor%20and%20suppressing%20CD44&journal=Oncol.%20Rep.&volume=41&pages=3393-3403&publication_year=2019&author=Ji%2CM&author=Liu%2CL&author=Hou%2CY&author=Li%2CB?
• How much does https://doi.org/10.1016%2Fj.stem.2018.11.017 generate monthly?
• http://scholar.google.com/scholar_lookup?&title=Targeting%20cancer%20stemness%20in%20the%20clinic%3A%20from%20hype%20to%20hope&journal=Cell%20Stem%20Cell&doi=10.1016%2Fj.stem.2018.11.017&volume=24&pages=25-40&publication_year=2019&author=Saygin%2CC&author=Matei%2CD&author=Majeti%2CR&author=Reizes%2CO&author=Lathia%2CJD's revenue stream
• Monthly income for https://doi.org/10.1016%2Fj.canlet.2019.03.027
• http://scholar.google.com/scholar_lookup?&title=Protective%20autophagy%20decreases%20osimertinib%20cytotoxicity%20through%20regulation%20of%20stem%20cell-like%20properties%20in%20lung%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2019.03.027&volume=452&pages=191-202&publication_year=2019&author=Li%2CL's total income per month
• How much does https://doi.org/10.1038%2Fs41388-018-0589-1 make?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Cancer%20stem-like%20properties%20and%20gefitinib%20resistance%20are%20dependent%20on%20purine%20synthetic%20metabolism%20mediated%20by%20the%20mitochondrial%20enzyme%20MTHFD2&journal=Oncogene&doi=10.1038%2Fs41388-018-0589-1&volume=38&pages=2464-2481&publication_year=2019&author=Nishimura%2CT each month?
• Monthly income for https://doi.org/10.18632%2Foncotarget.3389
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=IL-8%20confers%20resistance%20to%20EGFR%20inhibitors%20by%20inducing%20stem%20cell%20properties%20in%20lung%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.3389&volume=6&pages=10415-10431&publication_year=2015&author=Liu%2CYN
• What's https://doi.org/10.1002%2Fstem.29's gross income?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Functional%20evidence%20that%20the%20self-renewal%20gene%20NANOG%20regulates%20human%20tumor%20development&journal=Stem%20Cells&doi=10.1002%2Fstem.29&volume=27&pages=993-1005&publication_year=2009&author=Jeter%2CCR
• Monthly income for https://doi.org/10.1158%2F0008-5472.CAN-10-3320
• How much does http://scholar.google.com/scholar_lookup?&title=HIF%20induces%20human%20embryonic%20stem%20cell%20markers%20in%20cancer%20cells&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-10-3320&volume=71&pages=4640-4652&publication_year=2011&author=Mathieu%2CJ gross monthly?
• What's the monthly money flow for https://doi.org/10.1016%2Fj.suronc.2013.08.001?
• How much money does http://scholar.google.com/scholar_lookup?&title=Nanog%2C%20a%20novel%20prognostic%20marker%20for%20lung%20cancer&journal=Surg.%20Oncol.&doi=10.1016%2Fj.suronc.2013.08.001&volume=22&pages=224-229&publication_year=2013&author=Du%2CY generate?
• How much profit is https://doi.org/10.1158%2F1078-0432.CCR-14-2437 making per month?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Activation%20of%20vitamin%20D%20receptor%20signaling%20downregulates%20the%20expression%20of%20nuclear%20FOXM1%20protein%20and%20suppresses%20pancreatic%20cancer%20cell%20stemness&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-14-2437&volume=21&pages=844-853&publication_year=2015&author=Li%2CZ produce monthly?
• How much money does https://doi.org/10.1111%2Fcas.14237 generate?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Calcitriol%20inhibits%20migration%20and%20invasion%20of%20renal%20cell%20carcinoma%20cells%20by%20suppressing%20Smad2%2F3-%2C%20STAT3-%20and%20beta-catenin-mediated%20epithelial-mesenchymal%20transition&journal=Cancer%20Sci.&doi=10.1111%2Fcas.14237&volume=111&pages=59-71&publication_year=2020&author=Xu%2CS generate?
• How much money does https://doi.org/10.1016%2Fj.molimm.2017.09.006 generate?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=1%2C25%28OH%292D3%20induces%20regulatory%20T%20cell%20differentiation%20by%20influencing%20the%20VDR%2FPLC-gamma1%2FTGF-beta1%2Fpathway&journal=Mol.%20Immunol.&doi=10.1016%2Fj.molimm.2017.09.006&volume=91&pages=156-164&publication_year=2017&author=Zhou%2CQ
• How much does https://doi.org/10.1038%2Fs41556-018-0062-y generate monthly?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=PSPC1%20mediates%20TGF-beta1%20autocrine%20signalling%20and%20Smad2%2F3%20target%20switching%20to%20promote%20EMT%2C%20stemness%20and%20metastasis&journal=Nat.%20Cell%20Biol.&doi=10.1038%2Fs41556-018-0062-y&volume=20&pages=479-491&publication_year=2018&author=Yeh%2CHW?
• What's https://doi.org/10.1111%2Ffebs.14162's gross income?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=TGF-beta1-induced%20CK17%20enhances%20cancer%20stem%20cell-like%20properties%20rather%20than%20EMT%20in%20promoting%20cervical%20cancer%20metastasis%20via%20the%20ERK1%2F2-MZF1%20signaling%20pathway&journal=FEBS%20J.&doi=10.1111%2Ffebs.14162&volume=284&pages=3000-3017&publication_year=2017&author=Wu%2CL?
• Income figures for https://doi.org/10.1016%2Fj.biopha.2015.10.018
• How much profit does http://scholar.google.com/scholar_lookup?&title=TGF-beta1%20induces%20erlotinib%20resistance%20in%20non-small%20cell%20lung%20cancer%20by%20down-regulating%20PTEN&journal=Biomed.%20Pharmacother.&doi=10.1016%2Fj.biopha.2015.10.018&volume=77&pages=1-6&publication_year=2016&author=Shen%2CH make?
• What's the monthly money flow for https://doi.org/10.1158%2F1535-7163.MCT-13-0448?
• How much does http://scholar.google.com/scholar_lookup?&title=MiR-134%2F487b%2F655%20cluster%20regulates%20TGF-beta-induced%20epithelial-mesenchymal%20transition%20and%20drug%20resistance%20to%20gefitinib%20by%20targeting%20MAGI2%20in%20lung%20adenocarcinoma%20cells&journal=Mol.%20Cancer%20Ther.&doi=10.1158%2F1535-7163.MCT-13-0448&volume=13&pages=444-453&publication_year=2014&author=Kitamura%2CK make?
• What's the revenue for https://doi.org/10.1038%2Fncomms1880?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Loss-of-function%20of%20inositol%20polyphosphate-4-phosphatase%20reversibly%20increases%20the%20severity%20of%20allergic%20airway%20inflammation&journal=Nat.%20Commun.&doi=10.1038%2Fncomms1880&volume=3&publication_year=2012&author=Aich%2CJ&author=Mabalirajan%2CU&author=Ahmad%2CT&author=Agrawal%2CA&author=Ghosh%2CB?
• How much profit does https://doi.org/10.1073%2Fpnas.1009472107 generate?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=TGF-beta%20IL-6%20axis%20mediates%20selective%20and%20adaptive%20mechanisms%20of%20resistance%20to%20molecular%20targeted%20therapy%20in%20lung%20cancer&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.1009472107&volume=107&pages=15535-15540&publication_year=2010&author=Yao%2CZ?
• How much money does https://link.springer.com/doi/10.1186/s13046-019-1120-4 generate?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Co-administration%20of%2020%28S%29-protopanaxatriol%20%28g-PPT%29%20and%20EGFR-TKI%20overcomes%20EGFR-TKI%20resistance%20by%20decreasing%20SCD1%20induced%20lipid%20accumulation%20in%20non-small%20cell%20lung%20cancer&journal=J.%20Exp.%20Clin.%20Cancer%20Res&doi=10.1186%2Fs13046-019-1120-4&volume=38&publication_year=2019&author=Huang%2CQ
• Revenue of https://link.springer.com/doi/10.1186/s13046-018-0894-0
• http://scholar.google.com/scholar_lookup?&title=FOXC1%20induces%20cancer%20stem%20cell-like%20properties%20through%20upregulation%20of%20beta-catenin%20in%20NSCLC&journal=J.%20Exp.%20Clin.%20Cancer%20Res.&doi=10.1186%2Fs13046-018-0894-0&volume=37&publication_year=2018&author=Cao%2CS's revenue stream
• Revenue of https://doi.org/10.1158%2F1078-0432.CCR-13-2613
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Metformin%20sensitizes%20EGFR-TKI-resistant%20human%20lung%20cancer%20cells%20in%20vitro%20and%20in%20vivo%20through%20inhibition%20of%20IL-6%20signaling%20and%20EMT%20reversal&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-13-2613&volume=20&pages=2714-2726&publication_year=2014&author=Li%2CL
• What's the financial gain of https://citation-needed.springer.com/v2/references/10.1038/s41419-020-02908-w?format=refman&flavour=references?
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhirong%20Jia
• What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhirong%20Jia%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yameng%20Zhang's financial summary
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yameng%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Aiwen%20Yan's financial summary
• Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Aiwen%20Yan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Meisa%20Wang?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Meisa%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Qiushuang%20Han earn?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Qiushuang%20Han%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kaiwei%20Wang generate monthly?
• How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kaiwei%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jie%20Wang
• How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jie%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chen%20Qiao gross monthly?
• Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chen%20Qiao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhenzhen%20Pan
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhenzhen%20Pan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chuansheng%20Chen rake in every month?
• Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chuansheng%20Chen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dong%20Hu have monthly?
• What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dong%20Hu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xuansheng%20Ding have monthly?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xuansheng%20Ding%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
• Income figures for http://creativecommons.org/licenses/by/4.0/
• What's the financial outcome of https://s100.copyright.com/AppDispatchServlet?title=1%2C25-dihydroxyvitamin%20D3%20signaling-induced%20decreases%20in%20IRX4%20inhibits%20NANOG-mediated%20cancer%20stem-like%20properties%20and%20gefitinib%20resistance%20in%20NSCLC%20cells&author=Zhirong%20Jia%20et%20al&contentID=10.1038%2Fs41419-020-02908-w©right=The%20Author%28s%29&publication=2041-4889&publicationDate=2020-08-20&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY?
• What's the income generated by https://crossmark.crossref.org/dialog/?doi=10.1038/s41419-020-02908-w each month?
• What's the financial outcome of https://citation-needed.springer.com/v2/references/10.1038/s41419-020-02908-w?format=refman&flavour=citation?
• How much profit is https://doi.org/10.1007/s10555-024-10171-0 making per month?
• What's https://doi.org/10.1186/s12943-023-01877-w's gross income?
• What are the total earnings of https://doi.org/10.1007/s12032-023-02210-7?
• How much money does https://doi.org/10.1038/s41420-022-00918-5 generate?
• What's the total monthly financial gain of https://www.protocols.io/?
• What's the income generated by https://www.natureindex.com/ each month?
• How profitable is http://www.naturechina.com?
• Income figures for https://www.natureasia.com/ja-jp

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref